ABVC BioPharma logo

ABVC BioPharma

ABVC | NASDAQ
Chart Builder DCF Calculator
$0.94
+$0.03 (+3.30%)
At close: Nov 16, 2026, 4:00 PM ET
$0.96
+$0.02 (+2.00%)
After-hours: Nov 16, 2026, 7:28 PM ET
+3.30%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
39.5
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #538/1021 (Top 53%)

Key Statistics

Market Data

Market Cap $25.36M
1D Range
0.91 1.00
52W Range
0.71 2.92

Valuation (TTM)

PE -4.70
PB 1.94
EV/EBITDA -3.94

Valuation (NTM)

Forward PE 0.70
Forward PEG 0.04
Price Target $0.00
Loading financial charts...

Profile

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on creating novel drugs and medical devices to address critical, underserved healthcare requirements across the United States...

Sector Healthcare
Industry Biotechnology
Employees 18
IPO Date Nov 10, 2004
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Mar 18, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.